Abstract
Rare monogenic disorders of mitochondria have shed light on mitochondrial function, and the development of therapeutic agents for these disorders may be applicable to more common sporadic diseases characterized by mitochondrial dysfunction.
Original language | English |
---|---|
Pages (from-to) | 1132-1141 |
Number of pages | 10 |
Journal | New England Journal of Medicine |
Volume | 366 |
Issue number | 12 |
DOIs | |
Publication status | Published - 22 Mar 2012 |
Externally published | Yes |